Targeted activation of HNF4 α/HGF1/FOXA2 reverses hepatic fibrosis via exosome-mediated delivery of CRISPR/dCas9-SAM system

Nanomedicine, Ahead of Print.

Source: Nanomedicine - November 3, 2022 Category: Nanotechnology Authors: Nianan Luo Wenjun Zhong Jiangbin Li Zhongjie Zhai Jianguo Lu Rui Dong Source Type: research